A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1577-1585

  Chung, Che Sheng ^a   Hsiao, Jye Chian ^a,b   Chang, Yuan Shau ^a,b   Chang, Wen ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CHONDROITIN SULFATE; DERMATAN SULFATE; GENE PRODUCT; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN;

ARTICLE; CELL SURFACE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VACCINIA VIRUS; VIRION; VIRUS ADSORPTION; VIRUS INFECTION;

EID: 0031906150     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1577-1585.1998     Document Type: Article

References (52)

1. Baeuerle, P. A., and W. B. Huttner. 1986. Chlorate - a potent inhibitor of protein sulfation in intact cells. Biochem. Biophys. Res. Commun. 141:870-877.
2. Banfield, B. W., Y. Leduc, L. Esford, K. Schubert, and F. Tufaro. 1995. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69:3290-8.
3. Butcher, M., K. Raviprakash, and H. P. Ghosh. 1990. Acid pH induced fusion of cells by herpes simplex virus glycoproteins gB and gD. J. Biol. Chem. 265:5862-5868.
4. Chang, W., J.-C. Hsiao, C.-S. Chung, and C.-H. Bair. 1995. Isolation of a monoclonal antibody which blocks vaccinia virus infection. J. Virol. 69:517-522.
5. Dallo, S., J. F. Rodriguez, and M. Esteban. 1987. A 14K. envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus. Virology 159:423-32.
6. Davison, A. J., and B. Moss. 1989. Structure of vaccinia virus early promoters. J. Mol. Biol. 210:749-769.
7. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
8. Doms, R. W., R. Blumenthal, and B. Moss. 1990. Fusion of intra-and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 64:4884-4892.
9. Dubochet, J., M. Adrian, K. Richter, J. Garces, and R. Wittek. 1994. Structure of intracellular mature vaccinia virus observed by cryoelectron microscopy. J. Virol. 68:1935-1941.
10. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
11. Gomez Yafal, A., G. Kaplan, V. R. Racaniello, and J. M. Hogle. 1993. Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology 197:501-505.
12. r envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus. J. Virol. 63:4507-4514.
13. Gong, S. C., C. F. Lai, and M. Esteban. 1990. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology 178:81-91.
14. Greve, H., Z. Cully, P. Blumberg, and H. Kresse. 1988. Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. J. Biol. Chem. 263:12886-12892.
15. Gruenheid, S., L. Gatzke, H. Meadows, and F. Tufaro. 1993. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J. Virol. 67:93-100.
16. Haywood, A. M. 1994. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J. Virol. 68:1-5.
17. Heinegard, D., A. Franzen, E. Hedbom, and Y. Sommarian. 1986. Common structures of the core proteins of interstitial proteoglycans. John Wiley & Sons, Chichester, United Kingdom.
18. Herold, B. C., S. I. Gerber, T. Polonsky, B. J. Belval, P. N. Shaklee, and K. Holme. 1995. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology 206:1108-1116.
19. Herold, B. C., D. WuDunn, N. Soltys, and P. G. Spear. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1090-1098.
20. Jackson, T., F. M. Ellard, R. A. Ghazaleh, S. M. Brookes, W. E. Blakemore, A. H. Corteyn, D. I. Stuart, W. I. Newman, and A. Q. King. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface haparan sulfate. J. Virol. 70:5282-5287.
21. Joklik, W. K. 1962. The purification of four strains of poxvirus. Virology 18:9-18.
22. Kaplan, G., M. S. Freistadt, and V. R. Racaniello. 1990. Neutralization of poliovirus by cell receptors expressed in insect cells. J. Virol. 64:4697-4702.
23. Keller, K. M., P. B. Brauer, and J. M. Keller. 1989. Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28:8100-8107.
24. Kjellen, L., and U. Lindahl. 1991. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60:443-475.
25. Lai, C., S. Gong, and M. Esteban. 1990. Structural and functional properties of the 14-kDa envelope protein of vaccinia virus synthesized in Escherichia coli. J. Biol. Chem. 265:22174-22180.
26. Lindahl, U. 1989. Heparin: chemical and biological properties, clinical applications. Edward Arnold, London, United Kingdom.
27. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-77.
28. Love, D. C., J. D. Esko, and D. M. Mosser. 1993. A heparin-binding activity on Leishmania amastigotes which mediates adhesion to cellular proteoglycans. J. Cell Biol. 123:759-766.
29. Mendelsohn, C. L., E. Wimmer, and V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855-865.
30. Meyer, H., N. Osterrieder, and C.-P. Czerny. 1994. Identification of binding sites for neutralizing monoclonal antibodies on the 14-kDa fusion protein of orthopox viruses. Virology 200:778-783.
31. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/ NGF receptor family. Cell 87:427-36.
32. Mulder, G. I. 1981. Sulfation of drugs and related compounds. CRL Press, Boca Raton, Fla.
33. Paez, E., S. Dallo, and M. Esteban. 1987. Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence. J. Virol. 61:2642-2647.
34. Pogo, B. G., and S. Dales. 1981. Biology of poxviruses. Springer-Verlag, New York, N.Y.
35. Racaniello, V. R. 1996. Early events in poliovirus infection: virus-receptor interactions. Proc. Natl. Acad. Sci. USA 93:11378-11381.
36. Racaniello, V. R. 1991. Virus-receptor interaction in poliovirus entry and pathogenesis. Harvey Lect. 87:1-16.
37. Racaniello, V. R., and R. Ren. 1994. Transgenic mice and the pathogenesis of poliomyelitis. Arch. Virol. Suppl. 9:79-86.
38. Rodriguez, J. F., and M. Esteban. 1987. Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J. Virol. 61:3550-3554.
39. r enveloped protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J. Virol. 61:395-404.
40. Rucker, J., M. Samson, B. J. Doranz, F. Libert, J. F. Berson, Y. Yi, R. J. Smyth, R. G. Collman, C. C. Broder, G. Vassart, R. W. Doms, and M. Parmentier. 1996. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437-46.
41. Ruoslahti, E. 1989. Proteoglycans in cell regulation. J. Biol. Chem. 264:13369-13372.
42. Shieh, M.-T., and P. G. Spear. 1994. Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J. Virol. 68:1224-1228.
43. Shieh, M. T., D. WuDunn, R. I. Montgomery, J. D. Esko, and P. G. Spear. 1992. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1273-1281.
44. Sodeik, B., S. Cudmore, M. Ericsson, M. Esteban, E. G. Niles, and G. Griffiths. 1995. Assembly of vaccinia virus: incorporalion of p14 and p32 into the membrane of the intracellular mature virus. J. Virol. 69:3560-3574.
45. Spear, P. G. 1993. Entry of alphaherpesviruses into cells. Semin. Virol. 4:167-180.
46. Spear, P. G., M. T. Shieh, B. C. Herold, D. WuDunn, and T. I. Koshy. 1992. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv. Exp. Med. Biol. 313:341-353.
47. Subramanian, G., D. S. McClain, A. Perez, and A. O. Fuller. 1994. Swine testis cells contain functional heparan sulfate but are defective in entry of herpes simplex virus. J. Virol. 68:5667-5676.
48. Vanderplasschen, A., and G. L. Smith. 1997. A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J. Virol. 71:4032-4041.
49. van Putten, J. P. M., and S. M. Paul. 1995. Binding of syndecan-like cell surface proteoglycan receptor is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J. 14:2144-2154.
50. Wimmer, E. 1994. Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
51. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-8.
52. Zaretzky, F. R., R. Pearce-Pratt, and D. M. Phillips. 1995. Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia. Infect. Immun. 63:3520-3526.